Walleye Capital LLC Ardelyx, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $47,238 - $72,393	14,625 New	14,625 $49,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $928,261 - $2.27 Million	1,573,325 New	1,573,325 $1.87 Million
Q3 2020 Nov 16, 2020	SELL	$5.25 - $7.08 $100,794 - $135,928	-19,199 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $19,326 - $29,187	3,599 Added 23.07%	19,199 $133,000
Q1 2020 May 15, 2020	BUY	$4.35 - $8.79 $67,860 - $137,124	15,600 New	15,600 $89,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.